Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR Medicine, Hematology and Medical Oncology
Biography
Fingerprint
Dive into the research topics where Joshua Brody is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-priming
Aleynick, M., Svensson-Arvelund, J., Pantsulaia, G., Kim, K., Rose, S. A., Upadhyay, R., Yellin, M., Marsh, H., Oreper, D., Jhunjhunwala, S., Moussion, C. C., Merad, M., Brown, B. D. & Brody, J. D., 24 Jul 2023, In: Journal for ImmunoTherapy of Cancer. 11, 7, e007198.Research output: Contribution to journal › Article › peer-review
Open Access -
Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study
Kuruvilla, J., Armand, P., Hamadani, M., Kline, J., Moskowitz, C. H., Avigan, D., Brody, J. D., Ribrag, V., Herrera, A. F., Morschhauser, F., Kanate, A., Zinzani, P. L., Bitran, J., Ghesquieres, H., Schuster, S. J., Farooqui, M., Marinello, P. & Bartlett, N. L., 2023, In: Leukemia and Lymphoma. 64, 1, p. 130-139 10 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022)
Ascierto, P. A., Avallone, A., Bifulco, C., Bracarda, S., Brody, J. D., Emens, L. A., Ferris, R. L., Formenti, S. C., Hamid, O., Johnson, D. B., Kirchhoff, T., Klebanoff, C. A., Lesinski, G. B., Monette, A., Neyns, B., Odunsi, K., Paulos, C. M., Powell, D. J., Rezvani, K., Segal, B. H., & 4 others, Dec 2023, In: Journal of Translational Medicine. 21, 1, 488.Research output: Contribution to journal › Article › peer-review
Open Access -
ABCL-439 Subcutaneous Epcoritamab With Gemcitabine + Oxaliplatin (GemOx) Induced High Response Rates in Patients With Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Ineligible for Autologous Stem Cell Transplant (ASCT)
Brody, J., Wahlin, B. E., Phillips, T., Costello, R., Lugtenburg, P., Cordoba, R., Wang, L., Wu, J., Elliott, B., Abbas, A. & J⊘rgensen, J., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S379-S380Research output: Contribution to journal › Article › peer-review
-
ABCL-452 First-Line Treatment With Subcutaneous Epcoritamab + R-CHOP in Patients With High-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Phase 1/2 Data Update
Falchi, L., Offner, F., Belada, D., Brody, J., Linton, K. M., Karimi, Y., Cordoba, R., Snauwaert, S., Abbas, A., Wang, L., Wu, J., Elliott, B. & Clausen, M. R., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S380Research output: Contribution to journal › Article › peer-review
Press/Media
-
Lymphoma Research Foundation Awards More Than $5.4 Million in Lymphoma Research Grants.
2/05/23
1 item of Media coverage
Press/Media
-
Lymphoma Research Foundation Awards More Than $5.4 Million in Lymphoma Research Grants
2/05/23
77 items of Media coverage
Press/Media
-
-
Studies from Icahn School of Medicine at Mount Sinai Reveal New Findings on Oncolytic Virotherapy (Expanding Cross-presenting Dendritic Cells Enhances Oncolytic Virotherapy and Is Critical for Long-term Anti-tumor Immunity)
Ranjan Upadhyay, Brian Brown, Joshua Brody, Miriam Merad & Adolfo Garcia-Sastre
30/12/22
1 item of Media coverage
Press/Media
-
New funding of $2 million for research bringing us one step closer to a cure for Follicular Lymphoma
28/11/22 → 29/11/22
14 items of Media coverage
Press/Media